Similar Papers

Paper Title
Journal
Date
Author
Efficacy and safety of dovitinib in pretreated advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase II study
Myung-Ju Ahn ... Byoung Chul Cho
Journal of Thoracic Oncology | VOL. 11
Myung-Ju Ahn, et. al.Myung-Ju Ahn ... Byoung Chul Cho
26 Jan 2016
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Marina Chiara Garassino ...
Tumor Biology | VOL. 40
Marina Chiara Garassino, et. al.Marina Chiara Garassino ...
01 Nov 2018
Abstract LB-072: Impact of baseline serum cytokines on survival in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC) treated with nivolumab (nivo) or docetaxel (doc): Exploratory analyses from CheckMate 063 and CheckMate 017
Benedetto Farsaci ... Matthew D Hellmann
Cancer Research | VOL. 76
Benedetto Farsaci, et. al.Benedetto Farsaci ... Matthew D Hellmann
15 Jul 2016
Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer
Guocan Yu ... Jian Hu
Postgraduate Medicine | VOL. 132
Guocan Yu, et. al.Guocan Yu ... Jian Hu
13 May 2020
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
A Perspective on the MARS2 Trial
Eric Lim ... Harvey Pass
Journal of Thoracic Oncology | VOL. -
Eric Lim, et. al.Eric Lim ... Harvey Pass
01 Jan 2025
Meeting Announcements
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
Editorial Board
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
Board of Directors
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.